When: Price at $279

Then: Alert for potential add trigger

HOLD

• ATR of $10.75 means a typical daily swing exceeds the aggressive analyst's entire $6.60 stop distance
• MACD histogram is negative at minus 0.62, 50 SMA is declining, and VWMA confirms volume-weighted sellers in control
• Forward P/E of 25.3x trades at a 15-40% premium to the 10-year historical band of 18-22x, already pricing in recovery
• Beta of 1.325 means TXN falls approximately 6.6% in a 5% market drawdown; dividend outperformance already played out (12 points versus Nasdaq YTD)
• RSI at 39.96 with no bullish divergence indicates persistent weakness, not exhaustion; MACD at minus 4.68 with negative histogram shows decisive bearish momentum
• 200 SMA at $231.90 represents 12.6% downside; 50 SMA at $289.45 is 9% above current price; path of least resistance is sideways to lower
• Peer analog names (MCHP, STM, CRUS) down 9-12% in a month while TXN is down 8% represents relative strength within a de-rating sector, not a standalone positive
• Aggressive ADD stop at $259 (2.5% below) will be tested multiple times before any bounce plays out given the ATR of $10.75

→ vs aggressive: The reward-to-risk framing of 7-to-1 ignores that a 1.325 beta name with ATR of $10.75 in a 19-year high rate environment doesn't move on the aggressive analyst's schedule; the MACD histogram at minus 0.62 and declining 50 SMA confirm the trend is broken

→ vs aggressive: The forward P/E of 25.3x ALREADY reflects the market anchoring to forward margins; paying for the recovery that materializes exactly as expected puts us at roughly fair value, not asymmetric upside

→ vs aggressive: The dividend rotation trade has already played out (12 points outperformance versus Nasdaq YTD); the question is whether 1.325 beta compensates for drawdown risk in risk-off, not whether quality compounders deserve a bid

→ vs aggressive: Peer relative strength (TXN -8% vs MCHP/STM/CRUS -9-12%) is relative strength within a de-rating sector; institutional fund citations from Q2 are retrospectives on a $300+ stock, not actionable at $265 with the chart breaking down

→ vs aggressive: RSI at 39.96 without bullish divergence is persistent weakness, not oversold exhaustion; the only bullish reads (Bollinger band tag, ATR compression) are exhaustion signals, not reversal signals

→ vs aggressive: The ADD with stop at $259 (2.5% loss on new tranche) versus HOLD with hard stop at $231.90 (12.6% loss on existing position) is not asymmetric upside in the right direction—it creates multiple decision points where the trader gets stopped out and chases or sits in cash paying transaction costs for nothing

HOLD with tactical add; monetize via covered calls

• Tactical starter position at $265 with $259 stop, sized at ~1/3 of aggressive analyst's recommendation
• Mean reversion targets: VWMA at $277.27 (first) and 50 SMA at $289.45 (second)
• Tactical add risk is ~2.5% (~$6.60 stop distance) with 4-9% potential upside
• Intermediate trim trigger at $250 on heavy volume (midpoint between current price and 200 SMA)
• Core structural stop remains at 200 SMA ($231.90) but adds layered trim approach
• Covered call/collar strategy at $289 strike to monetize elevated IV and generate income
• RSI has pressed oversold 3 times in 3 weeks without sustained bounce — persistent weakness, not exhaustion
• ATR is $10.75, making the $6.60 stop distance vulnerable to noise flush before bounce plays out
• Beta of 1.325 means 6.5% drawdown in a 5% S&P risk-off event; dividend yield of 2.12% doesn't compensate
• Operating margins at 42.6% are structurally elevated vs historical 35% — justifies premium multiple
• Forward P/E of 25.3x vs historical band of 18-22x reflects structural quality, not overvaluation
• Upside from here is likely earnings-driven, not multiple-driven — bounded by multiple stability

→ vs aggressive: Bounce thesis timing is flawed — ATR of $10.75 means the $6.60 stop will likely be hit by noise before any mean reversion materializes; trade fails in execution despite looking clean on paper

→ vs aggressive: High beta (1.325) means dividend rotation thesis is fragile — in risk-off events TXN will fall ~6.5% vs 5% S&P drawdown, and 2.12% yield doesn't compensate for that drawdown risk

→ vs aggressive: Sizing for conviction rather than probability — counter-trend trades require smaller sizing relative to core position regardless of underlying story conviction

→ vs conservative: Wide 12.5% stop to $231.90 is not discipline — it's accepting massive losses to avoid making decisions; a 12% drawdown in high-beta name is already a significant capital loss

→ vs conservative: Confirmation gates will cost 8% of upside (path from $265 to $289) on a name averaging 5-8M shares/day volume; waiting for 7M share 50 SMA reclaim at $289.45 is a high bar on the way back up

→ vs conservative: Historical P/E band of 18-22x is wrong anchor when operating margins are structurally elevated at 42.6% vs historical 35% mean — market is rationally pricing higher-quality earnings stream